Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma

BACKGROUND: Post-surgical prognosis is usually poor for combined hepatocellular cholangiocarcinoma (CHCC-CC), a rare primary liver cancer. Although midkine (MK) is a prognostic biomarker for several known cancers, it is not known whether it can be used as such in resectable CHCC-CC. This study exami...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Ma, Ming-Chun, Chen, Yi-Ju, Chiu, Tai-Jan, Lan, Jui, Liu, Chien-Ting, Chen, Yi-Ching, Tien, Hsin-Ho, Chen, Yen-Yang
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5830052/
https://ncbi.nlm.nih.gov/pubmed/29486735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4146-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados